Literature DB >> 10366975

[Inhibitory effect of replication and expression of HDV by antisense oligodeoxynucleotides in H1 delta 9 cell].

H Li1, Q Mao, Q Li.   

Abstract

OBJECTIVE: To study inhibitory effect of an antisense oligodeoxynucleotide (ASODN) and its phosphorothioate (S-ASODN) on replication and expression of HDV in H1 delta 9 cell.
METHODS: In previous studies, it was proved that the ASODNs which are complementary to genomic HDV ribozyme self-cleavage site and stem I regions can inhibit availably genomic HDV ribozyme activity. In the present study, a 15-mer ASODN and S-ASODS which are complementary to this region (nucleotide 684-698) were added to medium of cultured H1 delta 9 cell. HDAg and HDV cDNA were detected by ELISA and Dot blot hybridization.
RESULTS: Twenty-fourth hour after 6 mumol/L ASODN and S-ASODN were added, both the secreting amount of HDAg in the supernatant and HDV RNA were inhibited. The inhibiting rates were 76.14% and 84.50% respectively. When the concentration of S-ASODN was 2, 4, 6 mumol/L, the inhibiting rate showed the feature of dosage dependence. Inhibitory effect of ASODN and S-ASODN were similar in the same dosage.
CONCLUSION: The results suggest that ASODN and S-ASODN can availably inhibit replication and expression of HDV in H1 delta 9 cell.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366975

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  2 in total

Review 1.  Management of hepatitis delta: Need for novel therapeutic options.

Authors:  Zaigham Abbas; Minaam Abbas
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

2.  Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability.

Authors:  Beatriz Pacin-Ruiz; María Francesca Cortese; David Tabernero; Sara Sopena; Josep Gregori; Selene García-García; Rosario Casillas; Adrián Najarro; Unai Aldama; Adriana Palom; Ariadna Rando-Segura; Anna Galán; Marta Vila; Mar Riveiro-Barciela; Josep Quer; Gloria González-Aseguinolaza; María Buti; Francisco Rodríguez-Frías
Journal:  Viruses       Date:  2022-01-22       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.